serw-MX  [xml]  
 


    
 Categorias DeCS

A01 Body Regions .
A01.378 Extremities .
A01.378.610 Lower Extremity .
A01.378.610.400 Hip 5097 .
B03 Bacteria .
B03.440 Gram-Negative Bacteria .
B03.440.400 Gram-Negative Aerobic Bacteria .
B03.440.400.425 Gram-Negative Aerobic Rods and Cocci .
B03.440.400.425.297 Coxiellaceae .
B03.440.400.425.297.150 Coxiella .
B03.660 Proteobacteria .
B03.660.250 Gammaproteobacteria .
B03.660.250.132 Coxiellaceae .
B03.660.250.132.150 Coxiella .
C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.214 Bone Malalignment .
C05.116.214.500 Bone Anteversion .
C05.116.214.500.500 Coxa Vara .
C05.116.852 Osteonecrosis .
C05.116.852.175 Femur Head Necrosis .
C05.116.852.175.570 Legg-Calve-Perthes Disease .
C23 Pathological Conditions, Signs and Symptoms .
C23.300 Pathological Conditions, Anatomical .
C23.300.970 Torsion Abnormality .
C23.300.970.249 Bone Anteversion .
C23.300.970.249.500 Coxa Vara .
D02 Organic Chemicals .
D02.355 Ethers .
D02.355.291 Ethers, Cyclic .
D02.355.291.705 Okadaic Acid .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.310 Cyclooxygenase Inhibitors .
D27.505.519.389.310.500 Cyclooxygenase 2 Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.663 Peripheral Nervous System Agents .
D27.505.696.663.850 Sensory System Agents .
D27.505.696.663.850.014 Analgesics .
D27.505.696.663.850.014.040 Analgesics, Non-Narcotic .
D27.505.696.663.850.014.040.500 Anti-Inflammatory Agents, Non-Steroidal .
D27.505.696.663.850.014.040.500.500 Cyclooxygenase Inhibitors .
D27.505.696.663.850.014.040.500.500.500 Cyclooxygenase 2 Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.158 Anti-Inflammatory Agents .
D27.505.954.158.030 Anti-Inflammatory Agents, Non-Steroidal .
D27.505.954.158.030.500 Cyclooxygenase Inhibitors .
D27.505.954.158.030.500.500 Cyclooxygenase 2 Inhibitors .
D27.505.954.329 Antirheumatic Agents .
D27.505.954.329.030 Anti-Inflammatory Agents, Non-Steroidal .
D27.505.954.329.030.500 Cyclooxygenase Inhibitors .
D27.505.954.329.030.500.500 Cyclooxygenase 2 Inhibitors .
E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.740 Statistics as Topic .
E05.318.740.500 Models, Statistical .
E05.318.740.500.700 Proportional Hazards Models .
E05.318.740.600 Probability .
E05.318.740.600.700 Proportional Hazards Models .
E05.318.740.750 Regression Analysis .
E05.318.740.750.725 Proportional Hazards Models .
E05.318.740.998 Survival Analysis .
E05.318.740.998.825 Proportional Hazards Models .
E05.599 Models, Theoretical .
E05.599.835 Models, Statistical .
E05.599.835.900 Proportional Hazards Models .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.750 Statistics as Topic .
N05.715.360.750.530 Models, Statistical .
N05.715.360.750.530.650 Proportional Hazards Models .
N05.715.360.750.625 Probability .
N05.715.360.750.625.650 Proportional Hazards Models .
N05.715.360.750.695 Regression Analysis .
N05.715.360.750.695.650 Proportional Hazards Models .
N05.715.360.750.795 Survival Analysis .
N05.715.360.750.795.825 Proportional Hazards Models .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.830 Statistics as Topic .
N06.850.520.830.500 Models, Statistical .
N06.850.520.830.500.700 Proportional Hazards Models .
N06.850.520.830.600 Probability .
N06.850.520.830.600.700 Proportional Hazards Models .
N06.850.520.830.750 Regression Analysis .
N06.850.520.830.750.725 Proportional Hazards Models .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Cyclooxygenase 2 Inhibitors .
COX-2 Inhibitors .
COX2 Inhibitors .
Coxibs .
Cyclooxygenase-2 Inhibitors .
COX 2 Inhibitors .
Inhibitors, COX-2 .
Inhibitors, COX2 .
Inhibitors, Cyclooxygenase 2 .
Inhibitors, Cyclooxygenase-2 .
0.50
78412
 
Coxiella .
0.48
2841
 
Hip 5097 .
Coxas .
Hips 5097 .
Coxa 5097 .
0.47
4507675
 
Okadaic Acid .
Ocadaic Acid .
Acid, Ocadaic .
Acid, Okadaic .
0.43
43570
 
Coxiellaceae .
Rickettsiella .
0.41
029
 
Legg-Calve-Perthes Disease .
Legg-Calve-Perthes Syndrome .
Legg-Calvé-Perthes Disease .
Legg-Calvé-Perthes Syndrome .
Osteochondritis Deformans .
Disease, Legg-Calve-Perthes .
Disease, Legg-Calvé-Perthes .
Disease, Legg-Perthes .
Disease, Perthes .
Legg Calve Perthes Disease .
Legg Calve Perthes Syndrome .
Legg Calvé Perthes Disease .
Legg Calvé Perthes Syndrome .
Legg Perthes Disease .
Osteochondritis Deforman .
Syndrome, Legg-Calve-Perthes .
Syndrome, Legg-Calvé-Perthes .
Coxa Plana .
Legg-Perthes Disease .
Perthes Disease .
0.39
1031651
 
Coxa Vara .
Acquired Coxa Vara .
Acquired Coxa Varus .
Congenital Coxa Varus .
Coxa Vara, Congenital .
Coxa Varus .
Developmental Coxa Vara .
Developmental Coxa Varus .
Infantile Coxa Vara .
Acquired Coxa Varas .
Congenital Coxa Varas .
Coxa Vara, Acquired .
Coxa Vara, Developmental .
Coxa Vara, Infantile .
Coxa Varas .
Coxa Varas, Acquired .
Coxa Varas, Congenital .
Coxa Varas, Developmental .
Coxa Varas, Infantile .
Coxa Varus, Acquired .
Coxa Varus, Congenital .
Coxa Varus, Developmental .
Developmental Coxa Varas .
Infantile Coxa Varas .
Vara, Coxa .
Varas, Coxa .
Varus, Coxa .
Congenital Coxa Vara .
0.37
158
 
Proportional Hazards Models .
Cox Models .
Cox Proportional Hazards Models .
Hazard Models .
Proportional Hazard Models .
Hazard Model .
Hazard Model, Proportional .
Hazard Models, Proportional .
Hazards Model .
Hazards Model, Proportional .
Hazards Models, Proportional .
Model, Hazard .
Model, Hazards .
Model, Proportional Hazard .
Model, Proportional Hazards .
Models, Cox .
Models, Hazard .
Models, Hazards .
Models, Proportional Hazard .
Proportional Hazard Model .
Proportional Hazards Model .
Hazards Models .
Models, Proportional Hazards .
0.36
11863417